4.8 Article

TOR Signaling and Rapamycin Influence Longevity by Regulating SKN-1/Nrf and DAF-16/FoxO

期刊

CELL METABOLISM
卷 15, 期 5, 页码 713-724

出版社

CELL PRESS
DOI: 10.1016/j.cmet.2012.04.007

关键词

-

资金

  1. NIH [GM62891, CA129105]
  2. Ellison Medical Foundation
  3. American Federation for Aging Research
  4. Starr Foundation
  5. Koch Institute
  6. DRC from NIDDK
  7. NIDDK [T32]
  8. ADA [F32 NRSA]
  9. JSPS
  10. Grants-in-Aid for Scientific Research [24580142] Funding Source: KAKEN

向作者/读者索取更多资源

The TOR kinase, which is present in the functionally distinct complexes TORC1 and TORC2, is essential for growth but associated with disease and aging. Elucidation of how TOR influences life span will identify mechanisms of fundamental importance in aging and TOR functions. Here we show that when TORC1 is inhibited genetically in C. elegans, SKN-1/Nrf, and DAF-16/FoxO activate protective genes, and increase stress resistance and longevity. SKN-1 also upregulates TORC1 pathway gene expression in a feedback loop. Rapamycin triggers a similar protective response in C. elegans and mice, but increases worm life span dependent upon SKN-1 and not DAF-16, apparently by interfering with TORC2 along with TORC1. TORC1, TORC2, and insulin/IGF-1-like signaling regulate SKN-1 activity through different mechanisms. We conclude that modulation of SKN-1/Nrf and DAF-16/FoxO may be generally important in the effects of TOR signaling in vivo and that these transcription factors mediate an opposing relationship between growth signals and longevity.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据